Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cancer

Date Submitted: Jul 18, 2025
Date Accepted: Mar 31, 2026

The final, peer-reviewed published version of this preprint can be found here:

Gait Changes After a Mobile Health Exercise Intervention in Older Adults With Myeloid Neoplasms: Single-Arm Pilot Trial

Wang Y, Jensen-Battaglia M, Lin PJ, Kleckner I, Hayward E, Mendler J, Liesveld J, LoCastro M, Fallone C, Mortaz S, Dunne R, Mustian K, Loh KP

Gait Changes After a Mobile Health Exercise Intervention in Older Adults With Myeloid Neoplasms: Single-Arm Pilot Trial

JMIR Cancer 2026;12:e80909

DOI: 10.2196/80909

PMID: 42054674

Gait Changes After a Mobile Health Exercise Intervention in Older Adults With Myeloid Neoplasms: Single-Arm Pilot Study

  • Ying Wang; 
  • Marielle Jensen-Battaglia; 
  • Po-Ju Lin; 
  • Ian Kleckner; 
  • Elisabeth Hayward; 
  • Jason Mendler; 
  • Jane Liesveld; 
  • Marissa LoCastro; 
  • Cait Fallone; 
  • Soroush Mortaz; 
  • Richard Dunne; 
  • Karen Mustian; 
  • Kah Poh Loh

ABSTRACT

Background:

Cancer and chemotherapy can cause gait disturbances and increase fall risk in older adults with myeloid neoplasms (MN). Exercise may improve gait but research is lacking.

Objective:

We assessed gait changes following a mobile health exercise intervention during two cycles of outpatient chemotherapy (8-12 weeks).

Methods:

In a single arm pilot study, we included adults aged ≥60 with MN undergoing chemotherapy. GO-EXCAP integrates a progressive aerobic walking and resistance exercise program with a mobile app. We assessed gait using a waist-worn G-Walk motion sensor during a 6-minute walk at pre- and post-intervention. Spatio-temporal outcomes included cadence (steps/minute), velocity (meters/minute), normalized stride (stride length normalized over height), and swing duration (percentage of the gait cycle during which a foot is in the air when walking). Regularity outcomes that measure gait rhythm included variability of normalized stride and variability of swing duration. Variability for both outcomes was quantified as the standard deviation across all gait cycles. We calculated Cohen's d effect sizes (ES) for change in gait outcomes and used Spearman’s to correlate changes in daily steps and resistance exercise duration with gait outcomes.

Results:

We included 13 patients (mean age=71 years). Averaged daily steps were 3084 at pre- and 3757 at post-intervention. Patients performed resistance exercises for 25 min/day, 4 days/week at low intensity (rate of perceived exertion 3/10). At post-intervention, patients had increased cadence (+5 steps/minute; ES=0.38) and decreased variability in normalized stride (mean=-1.4; ES=-0.18) and swing duration (mean=-0.10%; ES=-0.15). Increased daily steps correlated with decreased swing duration variability (r=-0.72, p=0.01). Resistance exercise duration correlated with increased cadence (r=0.54, p=0.06) and velocity (r=0.56, p=0.05).

Conclusions:

GO-EXCAP shows promise in improving gait in older adults with MN. Better adherence to exercise correlated with improved gait outcomes. Clinical Trial: ClinicalTrials.gov identifier: NCT04035499


 Citation

Please cite as:

Wang Y, Jensen-Battaglia M, Lin PJ, Kleckner I, Hayward E, Mendler J, Liesveld J, LoCastro M, Fallone C, Mortaz S, Dunne R, Mustian K, Loh KP

Gait Changes After a Mobile Health Exercise Intervention in Older Adults With Myeloid Neoplasms: Single-Arm Pilot Trial

JMIR Cancer 2026;12:e80909

DOI: 10.2196/80909

PMID: 42054674

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.